Università degli Studi di Cagliari
Elena Massa
Does preoperative administration of Lugol’s solution in patients undergoing thyroidectomy for Graves’ disease really improve surgical outcomes? A propensity score matching analysis from six high-volume centers (StELLinA study)
2026-01-01 Canu, Gian Luigi; Medas, Fabio; Cappellacci, Federico; Lanzolla, Giulia; Rossi, Leonardo; Pennestrì, Francesco; Di Filippo, Giacomo; Chorti, Angeliki; Gjeloshi, Benard; Martullo, Annamaria; Pliakos, Ioannis; Lazzari, Giovanni; Morelli, Eleonora; Fantina, Lisa; De Manzini, Nicolò; Boi, Francesco; Dobrinja, Chiara; Papavramidis, Theodosios; Materazzi, Gabriele; Raffaelli, Marco; Calò, Pietro Giorgio; Puddu, Giulia; Ragno, Erica; Corrias, Silvia; Mura, Chiara; Sacco, Luisa; Dekova, Klaudiya; De Palma, Andrea; D'Amore, Annamaria; Gallucci, Pierpaolo; Prioli, Francesca; Tsalkatidou, Despoina; Mpontsiou, Ioannis; Kolonis, Triantafyllos; Eramo, Rita; Ciriotto, Davide; Gobbo, Giulia; Bonifazi, Claudia
De-Escalating Thyroid Cancer Surgery: Insights and Unresolved Questions From the 2025 ATA Guidelines
2026-01-01 Medas, F.; Canu, G. L.; Cappellacci, F.; Lanzolla, G.; Corrias, S.; Boi, F.; Calò, P. G.
Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression
2026-01-01 Lanzolla, Giulia; Saba, Francesca; Corrias, Silvia; Lixi, Filippo; Faa, Giulia; Colleo, Alessandro; Mura, Chiara; Canu, Gian Luigi; Cappellacci, Federico; Cuccu, Alberto; Giannaccare, Giuseppe; Mariotti, Stefano; Boi, Francesco
Risk of Complications in Patients Undergoing Thyroidectomy for Graves' Disease (LUNA Study)
2026-01-01 Canu, Gian Luigi; Medas, Fabio; Cappellacci, Federico; Lanzolla, Giulia; Rossi, Leonardo; Di Filippo, Giacomo; Chorti, Angeliki; Pliakos, Ioannis; Lazzari, Giovanni; Morelli, Eleonora; Dekova, Klaudiya; Sacco, Luisa; Fantina, Lisa; De Manzini, Nicolò; Boi, Francesco; Bakkar, Sohail; Dobrinja, Chiara; Papavramidis, Theodosios; Materazzi, Gabriele; Calò, Pietro Giorgio
Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms
2026-01-01 Mura, Chiara; Corrias, Silvia; Lecca, Mara; Lai, Maria Letizia; Canu, Gian Luigi; Medas, Fabio; Mariotti, Stefano; Calò, Pietro Giorgio; Caria, Paola; Lanzolla, Giulia; Boi, Francesco
Risk of Neck Hematoma Following Thyroidectomy in Patients Taking Direct Oral Anticoagulants: A Propensity Score Matching Analysis from Nine High-Volume European Centers (RAGNO Study)
2025-01-01 Canu, Gian Luigi; Medas, Fabio; Cappellacci, Federico; Lanzolla, Giulia; Rossi, Leonardo; Pennestrì, Francesco; Di Filippo, Giacomo; Chorti, Angeliki; Gallucci, Pierpaolo; De Palma, Andrea; Enrico Ambrosini, Carlo; Pliakos, Ioannis; Moysidis, Moysis; Luzuy-Guarnero, Valentine; Bédat, Benoit; Salvi, Giulia; Elisa Tempera, Serena; Carnassale, Giulia; Mattia, Amelia; Lazzari, Giovanni; Guagni, Tommaso; Izzo, Martina; Boi, Francesco; Morelli, Eleonora; Feroci, Francesco; Traini, Emanuela; Princi, Pietro; Stefano Demarchi, Marco; Papavramidis, Theodosios; Raffaelli, Marco; Materazzi, Gabriele; De Crea, Carmela; Calo', Pietro Giorgio
Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women
2025-01-01 Tassi, A.; Londero, A. P.; Xholli, A.; Lanzolla, G.; Bertozzi, S.; Savelli, L.; Prefumo, F.; Cagnacci, A.
Graves’ Disease: Is It Time for Targeted Therapy? A Narrative Review
2025-01-01 Viola, N.; Colleo, A.; Casula, M.; Mura, C.; Boi, F.; Lanzolla, G.
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ orbitopathy
2025-01-01 Lanzolla, G.; Rotondo Dottore, G.; Comi, S.; Cosentino, G.; Ciampa, D. A.; Sabini, E.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Rocchi, R.; Latrofa, F.; Figus, M.; Santini, F.; Marino, M.
Detection of Central Compartment Lymph Node Metastasis of Thyroid Cancer: Usefulness of Intraoperative Thyroglobulin Measurement in Fine Needle Aspiration Washout with and Without Blue Dye Injection
2025-01-01 Mura, C.; Canu, G. L.; Lanzolla, G.; Cappellacci, F.; Medas, F.; Mariotti, S.; Calo, P. G.; Boi, F.
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves’ Orbitopathy: A Retrospective Cohort Study
2025-01-01 Cosentino, G.; Lanzolla, G.; Comi, S.; Maglionico, M. N.; Posarelli, C.; Ciampa, D. A.; Menconi, F.; Rocchi, R.; Latrofa, F.; Figus, M.; Santini, F.; Marinò, M.
Long-term outcome of Graves’ orbitopathy following treatment with sirolimus
2024-01-01 Comi, S.; Cosentino, G.; Lanzolla, G.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Latrofa, F.; Rocchi, R.; Figus, M.; Santini, F.; Marino, M.
Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study
2024-01-01 Maglionico, M. N.; Lanzolla, G.; Figus, M.; Cosentino, G.; Comi, S.; Marino, M.; Santini, F.; Posarelli, C.
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation
2024-01-01 Khan, M. P.; Sabini, E.; Beigel, K.; Lanzolla, G.; Laslow, B.; Wang, D.; Merceron, C.; Giaccia, A.; Long, F.; Taylor, D.; Schipani, E.
Graves disease: latest understanding of pathogenesis and treatment options
2024-01-01 Lanzolla, G.; Marino, M.; Menconi, F.
Osteoblastic erythropoietin is not required for bone mass accrual
2024-01-01 Lanzolla, G.; Merceron, C.; Khan, M. P.; Sabini, E.; Giaccia, A.; Schipani, E.
Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency
2024-01-01 Lanzolla, Giulia; Sabini, Elena; Beigel, Katherine; Khan, Mohd Parvez; Sherry Liu, Xiaowei; Wang, Dian; Laslow, Brittany; Taylor, Deanne; Bellido, Teresita; Giaccia, Amato; Schipani, Ernestina
IgG4 serum levels in Graves’ orbitopathy
2024-01-01 Comi, S.; Lanzolla, G.; Cosentino, G.; Maglionico, M. N.; Posarelli, C.; Menconi, F.; Santini, F.; Elisei, R.; Marino, M.
Erythropoietin and skeletal cells crosstalks in physiology and disease
2023-01-01 Lanzolla, G.; Khan, M. P.; Sabini, E.; Giaccia, A.; Schipani, E.
Statins in Graves Orbitopathy: A New Therapeutic Tool
2023-01-01 Lanzolla, G.; Comi, S.; Cosentino, G.; Pakdel, F.; Marino, M.
Absence of a relationship between vitamin D and Graves’ orbitopathy
2023-01-01 Lanzolla, G.; Di Matteo, L.; Comi, S.; Cosentino, G.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Figus, M.; Marino, M.
Insights into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy
2023-01-01 Dottore, G. R.; Lanzolla, G.; Comi, S.; Menconi, F.; Mencacci, L. C.; Dallan, I.; Marcocci, C.; Marino, M.
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
2023-01-01 Lanzolla, G.; Puccinelli, L.; Giudetti, M.; Comi, S.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Figus, M.; Marcocci, C.; Marino, M.
Oxidative phosphorylation in bone cells
2023-01-01 Sabini, E.; Arboit, L.; Khan, M. P.; Lanzolla, G.; Schipani, E.
Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
2023-01-01 Schuh, A.; Ayvaz, G.; Baldeschi, L.; Baretic, M.; Bechtold, D.; Boschi, A.; Brix, T. H.; Burlacu, M. -C.; Ciric, J.; Covelli, D.; Curro, N.; Donati, S.; Eckstein, A. K.; Fichter, N.; Fuhrer, D.; Horn, M.; Jablonska-Pawlak, A.; Mandic, J. J.; Kahaly, G. J.; Konuk, O.; Langbein, A.; Lanzolla, G.; Marcocci, C.; Marino, M.; Miskiewicz, P.; Beleslin, B. N.; Perez-Lazaro, A.; Perez-Lopez, M.; Ponto, K. A.; Quinn, A.; Rudofsky, G.; Salvi, M.; Schittkowski, M. P.; Tanda, M. L.; Toruner, F.; Vaidya, B.; Hintschich, C. R.
Editorial: News in Graves’ orbitopathy: patients management and treatments
2023-01-01 Lanzolla, G.; Sabini, E.
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols
2022-01-01 Dallan, I.; Cristofani-Mencacci, L.; Fiacchini, G.; Benettini, G.; Picariello, M.; Lanzolla, G.; Lazzerini, F.; Rocchi, R.; Turri-Zanoni, M.; Menconi, F.; Sellari-Franceschini, S.; Marino, M.
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study
2022-01-01 Rotondo Dottore, G.; Torregrossa, L.; Lanzolla, G.; Mariotti, S.; Menconi, F.; Piaggi, P.; Cristofani Mencacci, L.; Posarelli, C.; Maglionico, M. N.; Dallan, I.; Figus, M.; Nardi, M.; Marcocci, C.; Basolo, F.; Marino, M.
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
2022-01-01 Gallo, D.; Mortara, L.; Veronesi, G.; Cattaneo, S. A. M.; Genoni, A.; Gallazzi, M.; Peruzzo, C.; Lasalvia, P.; Moretto, P.; Bruno, A.; Passi, A.; Pini, A.; Nauti, A.; Lavizzari, M. A.; Marino, M.; Lanzolla, G.; Tanda, M. L.; Bartalena, L.; Piantanida, E.
Sirolimus as a second-line treatment for Graves’ orbitopathy
2022-01-01 Lanzolla, G.; Maglionico, M. N.; Comi, S.; Menconi, F.; Piaggi, P.; Posarelli, C.; Figus, M.; Marcocci, C.; Marino, M.
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
2021-01-01 Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
2021-01-01 Lanzolla, G.; Menconi, F.; Nicoli, F.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
2021-01-01 Lanzolla, G.; Marino, M.; Marcocci, C.
Graves’ disease and Graves’ orbitopathy following COVID-19
2021-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Genetic Profiling of Orbital Fibroblasts from Patients with Graves' Orbitopathy
2021-01-01 Rotondo Dottore, G.; Bucci, I.; Lanzolla, G.; Dallan, I.; Sframeli, A.; Torregrossa, L.; Casini, G.; Basolo, F.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
2021-01-01 Lanzolla, G.; Sabini, E.; Leo, M.; Menconi, F.; Rocchi, R.; Sframeli, A.; Piaggi, P.; Nardi, M.; Marcocci, C.; Marino, M.
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis
2021-01-01 Rotondo Dottore, G.; Leo, M.; Ricciardi, R.; Maestri, M.; Bucci, I.; Lucchi, M.; Melfi, F.; Guida, M.; De Rosa, A.; Petrucci, L.; Ionni, I.; Lanzolla, G.; Nicoli, F.; Mantuano, M.; Ricci, D.; Latrofa, F.; Mariotti, S.; Marcocci, C.; Marino, M.
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy
2021-01-01 Bartalena, L.; Kahaly, G. J.; Baldeschi, L.; Dayan, C. M.; Eckstein, A.; Marcocci, C.; Marino, M.; Vaidya, B.; Wiersinga, W. M.; Ayvaz, G.; Konuk, O.; Ciric, J.; Beleslin, B.; Boschi, A.; Burlacu, M. C.; Morris, D.; Le Moli, R.; Marino, A.; Mckee, J.; Zammit, N.; Fuhrer, D.; Pereni, I.; Schittkowski, M.; Raddatz, D.; Lee, V.; Meeran, K.; Abeillon, J.; Thcong, T. S.; Ponto, K.; Muller, I.; Curro, N.; Hintschich, C.; Gartner, R.; Pearce, S.; Clarke, L.; Brix, T.; Bechtold, D.; Rudovfsky, G.; Fichter, N.; Du Pasquier, L.; Meney, J.; Menconi, F.; Lanzolla, G.; Sundar, G.; Yung, S. P.; Boboridis, K.; Anagnostis, P.; Lopez, M. P.; Sanchez, C. J.; Tanda, M. L.; Donati, S.; Papp, A.; Li, S.; Jablonska, A.; Miskiewicz, P.; Mandic, J. J.; Baretic, M.
Statins: A New Hope on the Horizon of Graves Orbitopathy?
2021-01-01 Marino, M.; Lanzolla, G.; Marcocci, C.
Antioxidant Therapy in Graves’ Orbitopathy
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
2020-01-01 Lanzolla, G.; Vannucchi, G.; Ionni, I.; Campi, I.; Sileo, F.; Lazzaroni, E.; Marino, M.
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis
2020-01-01 Marino, M.; Ionni, I.; Lanzolla, G.; Sframeli, A.; Latrofa, F.; Rocchi, R.; Marcocci, C.
Oxidative Stress in Graves Disease and Graves Orbitopathy
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study
2020-01-01 Lanzolla, G.; Ricci, D.; Nicolì, F.; Sabini, E.; Sframeli, A.; Brancatella, A.; Mantuano, M.; Dottore, G. R.; Bucci, I.; Figus, M.; Nardi, M.; Latrofa, F.; Marcocci, C.; Marinò, M.
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-l1 blockade: Insights from four cases
2019-01-01 Lupi, I.; Brancatella, A.; Cosottini, M.; Viola, N.; Lanzolla, G.; Sgro, D.; Di Dalmazi, G.; Latrofa, F.; Caturegli, P.; Marcocci, C.
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
2019-01-01 Marino, M.; Rotondo Dottore, G.; Ionni, I.; Lanzolla, G.; Sabini, E.; Ricci, D.; Sframeli, A.; Mazzi, B.; Menconi, F.; Latrofa, F.; Vitti, P.; Marcocci, C.; Chiovato, L.
Immune checkpoint blockade Anti-PD-L1 as a trigger for autoimmune polyendocrine syndrome
2019-01-01 Lanzolla, G.; Coppelli, A.; Cosottini, M.; Del Prato, S.; Marcocci, C.; Lupi, I.
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study
2018-01-01 Lanzolla, G.; Sabini, E.; Profilo, M. A.; Mazzi, B.; Sframeli, A.; Rocchi, R.; Menconi, F.; Leo, M.; Nardi, M.; Vitti, P.; Marcocci, C.; Marino, M.
Androgens and Hypertension in Men and Women: a Unifying View
2017-01-01 Moretti, C.; Lanzolla, G.; Moretti, M.; Gnessi, L.; Carmina, E.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| Does preoperative administration of Lugol’s solution in patients undergoing thyroidectomy for Graves’ disease really improve surgical outcomes? A propensity score matching analysis from six high-volume centers (StELLinA study) | 1-gen-2026 | Canu, Gian Luigi; Medas, Fabio; Cappellacci, Federico; Lanzolla, Giulia; Rossi, Leonardo; Pennestrì, Francesco; Di Filippo, Giacomo; Chorti, Angeliki; Gjeloshi, Benard; Martullo, Annamaria; Pliakos, Ioannis; Lazzari, Giovanni; Morelli, Eleonora; Fantina, Lisa; De Manzini, Nicolò; Boi, Francesco; Dobrinja, Chiara; Papavramidis, Theodosios; Materazzi, Gabriele; Raffaelli, Marco; Calò, Pietro Giorgio; Puddu, Giulia; Ragno, Erica; Corrias, Silvia; Mura, Chiara; Sacco, Luisa; Dekova, Klaudiya; De Palma, Andrea; D'Amore, Annamaria; Gallucci, Pierpaolo; Prioli, Francesca; Tsalkatidou, Despoina; Mpontsiou, Ioannis; Kolonis, Triantafyllos; Eramo, Rita; Ciriotto, Davide; Gobbo, Giulia; Bonifazi, Claudia | UPDATES IN SURGERY | - |
| De-Escalating Thyroid Cancer Surgery: Insights and Unresolved Questions From the 2025 ATA Guidelines | 1-gen-2026 | Medas, F.; Canu, G. L.; Cappellacci, F.; Lanzolla, G.; Corrias, S.; Boi, F.; Calò, P. G. | ANNALI ITALIANI DI CHIRURGIA | - |
| Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression | 1-gen-2026 | Lanzolla, Giulia; Saba, Francesca; Corrias, Silvia; Lixi, Filippo; Faa, Giulia; Colleo, Alessandro; Mura, Chiara; Canu, Gian Luigi; Cappellacci, Federico; Cuccu, Alberto; Giannaccare, Giuseppe; Mariotti, Stefano; Boi, Francesco | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - |
| Risk of Complications in Patients Undergoing Thyroidectomy for Graves' Disease (LUNA Study) | 1-gen-2026 | Canu, Gian Luigi; Medas, Fabio; Cappellacci, Federico; Lanzolla, Giulia; Rossi, Leonardo; Di Filippo, Giacomo; Chorti, Angeliki; Pliakos, Ioannis; Lazzari, Giovanni; Morelli, Eleonora; Dekova, Klaudiya; Sacco, Luisa; Fantina, Lisa; De Manzini, Nicolò; Boi, Francesco; Bakkar, Sohail; Dobrinja, Chiara; Papavramidis, Theodosios; Materazzi, Gabriele; Calò, Pietro Giorgio | OTOLARYNGOLOGY-HEAD AND NECK SURGERY | - |
| Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms | 1-gen-2026 | Mura, Chiara; Corrias, Silvia; Lecca, Mara; Lai, Maria Letizia; Canu, Gian Luigi; Medas, Fabio; Mariotti, Stefano; Calò, Pietro Giorgio; Caria, Paola; Lanzolla, Giulia; Boi, Francesco | EUROPEAN JOURNAL OF ENDOCRINOLOGY | - |
| Risk of Neck Hematoma Following Thyroidectomy in Patients Taking Direct Oral Anticoagulants: A Propensity Score Matching Analysis from Nine High-Volume European Centers (RAGNO Study) | 1-gen-2025 | Canu, Gian Luigi; Medas, Fabio; Cappellacci, Federico; Lanzolla, Giulia; Rossi, Leonardo; Pennestrì, Francesco; Di Filippo, Giacomo; Chorti, Angeliki; Gallucci, Pierpaolo; De Palma, Andrea; Enrico Ambrosini, Carlo; Pliakos, Ioannis; Moysidis, Moysis; Luzuy-Guarnero, Valentine; Bédat, Benoit; Salvi, Giulia; Elisa Tempera, Serena; Carnassale, Giulia; Mattia, Amelia; Lazzari, Giovanni; Guagni, Tommaso; Izzo, Martina; Boi, Francesco; Morelli, Eleonora; Feroci, Francesco; Traini, Emanuela; Princi, Pietro; Stefano Demarchi, Marco; Papavramidis, Theodosios; Raffaelli, Marco; Materazzi, Gabriele; De Crea, Carmela; Calo', Pietro Giorgio | JOURNAL OF CLINICAL MEDICINE | - |
| Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women | 1-gen-2025 | Tassi, A.; Londero, A. P.; Xholli, A.; Lanzolla, G.; Bertozzi, S.; Savelli, L.; Prefumo, F.; Cagnacci, A. | PHARMACEUTICALS | - |
| Graves’ Disease: Is It Time for Targeted Therapy? A Narrative Review | 1-gen-2025 | Viola, N.; Colleo, A.; Casula, M.; Mura, C.; Boi, F.; Lanzolla, G. | MEDICINA | - |
| In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ orbitopathy | 1-gen-2025 | Lanzolla, G.; Rotondo Dottore, G.; Comi, S.; Cosentino, G.; Ciampa, D. A.; Sabini, E.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Rocchi, R.; Latrofa, F.; Figus, M.; Santini, F.; Marino, M. | ENDOCRINE | - |
| Detection of Central Compartment Lymph Node Metastasis of Thyroid Cancer: Usefulness of Intraoperative Thyroglobulin Measurement in Fine Needle Aspiration Washout with and Without Blue Dye Injection | 1-gen-2025 | Mura, C.; Canu, G. L.; Lanzolla, G.; Cappellacci, F.; Medas, F.; Mariotti, S.; Calo, P. G.; Boi, F. | CANCERS | - |
| Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves’ Orbitopathy: A Retrospective Cohort Study | 1-gen-2025 | Cosentino, G.; Lanzolla, G.; Comi, S.; Maglionico, M. N.; Posarelli, C.; Ciampa, D. A.; Menconi, F.; Rocchi, R.; Latrofa, F.; Figus, M.; Santini, F.; Marinò, M. | THYROID | - |
| Long-term outcome of Graves’ orbitopathy following treatment with sirolimus | 1-gen-2024 | Comi, S.; Cosentino, G.; Lanzolla, G.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Latrofa, F.; Rocchi, R.; Figus, M.; Santini, F.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study | 1-gen-2024 | Maglionico, M. N.; Lanzolla, G.; Figus, M.; Cosentino, G.; Comi, S.; Marino, M.; Santini, F.; Posarelli, C. | FRONTIERS IN ENDOCRINOLOGY | - |
| HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation | 1-gen-2024 | Khan, M. P.; Sabini, E.; Beigel, K.; Lanzolla, G.; Laslow, B.; Wang, D.; Merceron, C.; Giaccia, A.; Long, F.; Taylor, D.; Schipani, E. | JCI INSIGHT | - |
| Graves disease: latest understanding of pathogenesis and treatment options | 1-gen-2024 | Lanzolla, G.; Marino, M.; Menconi, F. | NATURE REVIEWS. ENDOCRINOLOGY | - |
| Osteoblastic erythropoietin is not required for bone mass accrual | 1-gen-2024 | Lanzolla, G.; Merceron, C.; Khan, M. P.; Sabini, E.; Giaccia, A.; Schipani, E. | JBMR PLUS | - |
| Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency | 1-gen-2024 | Lanzolla, Giulia; Sabini, Elena; Beigel, Katherine; Khan, Mohd Parvez; Sherry Liu, Xiaowei; Wang, Dian; Laslow, Brittany; Taylor, Deanne; Bellido, Teresita; Giaccia, Amato; Schipani, Ernestina | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - |
| IgG4 serum levels in Graves’ orbitopathy | 1-gen-2024 | Comi, S.; Lanzolla, G.; Cosentino, G.; Maglionico, M. N.; Posarelli, C.; Menconi, F.; Santini, F.; Elisei, R.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Erythropoietin and skeletal cells crosstalks in physiology and disease | 1-gen-2023 | Lanzolla, G.; Khan, M. P.; Sabini, E.; Giaccia, A.; Schipani, E. | CURRENT OPINION IN ENDOCRINE AND METABOLIC RESEARCH | - |
| Statins in Graves Orbitopathy: A New Therapeutic Tool | 1-gen-2023 | Lanzolla, G.; Comi, S.; Cosentino, G.; Pakdel, F.; Marino, M. | OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY | - |
| Absence of a relationship between vitamin D and Graves’ orbitopathy | 1-gen-2023 | Lanzolla, G.; Di Matteo, L.; Comi, S.; Cosentino, G.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Figus, M.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Insights into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy | 1-gen-2023 | Dottore, G. R.; Lanzolla, G.; Comi, S.; Menconi, F.; Mencacci, L. C.; Dallan, I.; Marcocci, C.; Marino, M. | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - |
| Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy | 1-gen-2023 | Lanzolla, G.; Puccinelli, L.; Giudetti, M.; Comi, S.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Figus, M.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Oxidative phosphorylation in bone cells | 1-gen-2023 | Sabini, E.; Arboit, L.; Khan, M. P.; Lanzolla, G.; Schipani, E. | BONE REPORTS | - |
| Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) | 1-gen-2023 | Schuh, A.; Ayvaz, G.; Baldeschi, L.; Baretic, M.; Bechtold, D.; Boschi, A.; Brix, T. H.; Burlacu, M. -C.; Ciric, J.; Covelli, D.; Curro, N.; Donati, S.; Eckstein, A. K.; Fichter, N.; Fuhrer, D.; Horn, M.; Jablonska-Pawlak, A.; Mandic, J. J.; Kahaly, G. J.; Konuk, O.; Langbein, A.; Lanzolla, G.; Marcocci, C.; Marino, M.; Miskiewicz, P.; Beleslin, B. N.; Perez-Lazaro, A.; Perez-Lopez, M.; Ponto, K. A.; Quinn, A.; Rudofsky, G.; Salvi, M.; Schittkowski, M. P.; Tanda, M. L.; Toruner, F.; Vaidya, B.; Hintschich, C. R. | BRITISH JOURNAL OF OPHTHALMOLOGY | - |
| Editorial: News in Graves’ orbitopathy: patients management and treatments | 1-gen-2023 | Lanzolla, G.; Sabini, E. | FRONTIERS IN ENDOCRINOLOGY | - |
| Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols | 1-gen-2022 | Dallan, I.; Cristofani-Mencacci, L.; Fiacchini, G.; Benettini, G.; Picariello, M.; Lanzolla, G.; Lazzerini, F.; Rocchi, R.; Turri-Zanoni, M.; Menconi, F.; Sellari-Franceschini, S.; Marino, M. | AMERICAN JOURNAL OF OTOLARYNGOLOGY | - |
| Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study | 1-gen-2022 | Rotondo Dottore, G.; Torregrossa, L.; Lanzolla, G.; Mariotti, S.; Menconi, F.; Piaggi, P.; Cristofani Mencacci, L.; Posarelli, C.; Maglionico, M. N.; Dallan, I.; Figus, M.; Nardi, M.; Marcocci, C.; Basolo, F.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment | 1-gen-2022 | Gallo, D.; Mortara, L.; Veronesi, G.; Cattaneo, S. A. M.; Genoni, A.; Gallazzi, M.; Peruzzo, C.; Lasalvia, P.; Moretto, P.; Bruno, A.; Passi, A.; Pini, A.; Nauti, A.; Lavizzari, M. A.; Marino, M.; Lanzolla, G.; Tanda, M. L.; Bartalena, L.; Piantanida, E. | FRONTIERS IN ENDOCRINOLOGY | - |
| Sirolimus as a second-line treatment for Graves’ orbitopathy | 1-gen-2022 | Lanzolla, G.; Maglionico, M. N.; Comi, S.; Menconi, F.; Piaggi, P.; Posarelli, C.; Figus, M.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy | 1-gen-2021 | Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study | 1-gen-2021 | Lanzolla, G.; Menconi, F.; Nicoli, F.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease | 1-gen-2021 | Lanzolla, G.; Marino, M.; Marcocci, C. | FRONTIERS IN ENDOCRINOLOGY | - |
| Graves’ disease and Graves’ orbitopathy following COVID-19 | 1-gen-2021 | Lanzolla, G.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Genetic Profiling of Orbital Fibroblasts from Patients with Graves' Orbitopathy | 1-gen-2021 | Rotondo Dottore, G.; Bucci, I.; Lanzolla, G.; Dallan, I.; Sframeli, A.; Torregrossa, L.; Casini, G.; Basolo, F.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - |
| Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial | 1-gen-2021 | Lanzolla, G.; Sabini, E.; Leo, M.; Menconi, F.; Rocchi, R.; Sframeli, A.; Piaggi, P.; Nardi, M.; Marcocci, C.; Marino, M. | THE LANCET DIABETES & ENDOCRINOLOGY | - |
| Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis | 1-gen-2021 | Rotondo Dottore, G.; Leo, M.; Ricciardi, R.; Maestri, M.; Bucci, I.; Lucchi, M.; Melfi, F.; Guida, M.; De Rosa, A.; Petrucci, L.; Ionni, I.; Lanzolla, G.; Nicoli, F.; Mantuano, M.; Ricci, D.; Latrofa, F.; Mariotti, S.; Marcocci, C.; Marino, M. | EUROPEAN THYROID JOURNAL | - |
| The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy | 1-gen-2021 | Bartalena, L.; Kahaly, G. J.; Baldeschi, L.; Dayan, C. M.; Eckstein, A.; Marcocci, C.; Marino, M.; Vaidya, B.; Wiersinga, W. M.; Ayvaz, G.; Konuk, O.; Ciric, J.; Beleslin, B.; Boschi, A.; Burlacu, M. C.; Morris, D.; Le Moli, R.; Marino, A.; Mckee, J.; Zammit, N.; Fuhrer, D.; Pereni, I.; Schittkowski, M.; Raddatz, D.; Lee, V.; Meeran, K.; Abeillon, J.; Thcong, T. S.; Ponto, K.; Muller, I.; Curro, N.; Hintschich, C.; Gartner, R.; Pearce, S.; Clarke, L.; Brix, T.; Bechtold, D.; Rudovfsky, G.; Fichter, N.; Du Pasquier, L.; Meney, J.; Menconi, F.; Lanzolla, G.; Sundar, G.; Yung, S. P.; Boboridis, K.; Anagnostis, P.; Lopez, M. P.; Sanchez, C. J.; Tanda, M. L.; Donati, S.; Papp, A.; Li, S.; Jablonska, A.; Miskiewicz, P.; Mandic, J. J.; Baretic, M. | EUROPEAN JOURNAL OF ENDOCRINOLOGY | - |
| Statins: A New Hope on the Horizon of Graves Orbitopathy? | 1-gen-2021 | Marino, M.; Lanzolla, G.; Marcocci, C. | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - |
| Antioxidant Therapy in Graves’ Orbitopathy | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | FRONTIERS IN ENDOCRINOLOGY | - |
| Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy | 1-gen-2020 | Lanzolla, G.; Vannucchi, G.; Ionni, I.; Campi, I.; Sileo, F.; Lazzaroni, E.; Marino, M. | FRONTIERS IN ENDOCRINOLOGY | - |
| Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis | 1-gen-2020 | Marino, M.; Ionni, I.; Lanzolla, G.; Sframeli, A.; Latrofa, F.; Rocchi, R.; Marcocci, C. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Oxidative Stress in Graves Disease and Graves Orbitopathy | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | EUROPEAN THYROID JOURNAL | - |
| Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study | 1-gen-2020 | Lanzolla, G.; Ricci, D.; Nicolì, F.; Sabini, E.; Sframeli, A.; Brancatella, A.; Mantuano, M.; Dottore, G. R.; Bucci, I.; Figus, M.; Nardi, M.; Latrofa, F.; Marcocci, C.; Marinò, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Clinical heterogeneity of hypophysitis secondary to PD-1/PD-l1 blockade: Insights from four cases | 1-gen-2019 | Lupi, I.; Brancatella, A.; Cosottini, M.; Viola, N.; Lanzolla, G.; Sgro, D.; Di Dalmazi, G.; Latrofa, F.; Caturegli, P.; Marcocci, C. | ENDOCRINOLOGY, DIABETES & METABOLISM CASE REPORTS | - |
| Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy | 1-gen-2019 | Marino, M.; Rotondo Dottore, G.; Ionni, I.; Lanzolla, G.; Sabini, E.; Ricci, D.; Sframeli, A.; Mazzi, B.; Menconi, F.; Latrofa, F.; Vitti, P.; Marcocci, C.; Chiovato, L. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Immune checkpoint blockade Anti-PD-L1 as a trigger for autoimmune polyendocrine syndrome | 1-gen-2019 | Lanzolla, G.; Coppelli, A.; Cosottini, M.; Del Prato, S.; Marcocci, C.; Lupi, I. | JOURNAL OF THE ENDOCRINE SOCIETY | - |
| Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study | 1-gen-2018 | Lanzolla, G.; Sabini, E.; Profilo, M. A.; Mazzi, B.; Sframeli, A.; Rocchi, R.; Menconi, F.; Leo, M.; Nardi, M.; Vitti, P.; Marcocci, C.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Androgens and Hypertension in Men and Women: a Unifying View | 1-gen-2017 | Moretti, C.; Lanzolla, G.; Moretti, M.; Gnessi, L.; Carmina, E. | CURRENT HYPERTENSION REPORTS | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile